CGEN logo

CGEN
Compugen Ltd

2,583
Mkt Cap
$267.59M
Volume
250.00
52W High
$3.24
52W Low
$1.29
PE Ratio
7.72
CGEN Fundamentals
Price
$2.85
Prev Close
$2.83
Open
$2.82
50D MA
$2.48
Beta
1.60
Avg. Volume
556,546.88
EPS (Annual)
$0.3767
P/B
2.62
Rev/Employee
$970,186.67
$0.8571
Loading...
Loading...
News
all
press releases
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum PR Newswire HOLON, Israel, May 12, 2026 HOLON, Israel...
PR Newswire·2d ago
News Placeholder
More News
News Placeholder
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates
Janux Therapeutics (JANX) delivered earnings and revenue surprises of +21.83% and -75.11%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Compugen (NASDAQ:CGEN) Stock Price Crosses Above 200-Day Moving Average - What's Next?
Compugen (NASDAQ:CGEN) Share Price Crosses Above Two Hundred Day Moving Average - What's Next...
MarketBeat·9d ago
News Placeholder
BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates
BioMarin (BMRN) delivered earnings and revenue surprises of -18.96% and +0.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026 Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026 PR Newswire HOLON, Israel, May 4, 2026 HOLON, Israel, May...
PR Newswire·10d ago
News Placeholder
Compugen (NASDAQ:CGEN) CEO Eran Ophir Sells 5,000 Shares
Compugen Ltd. (NASDAQ:CGEN - Get Free Report) CEO Eran Ophir sold 5,000 shares of Compugen stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $3.20, for a...
MarketBeat·16d ago
News Placeholder
Insider Selling: Compugen (NASDAQ:CGEN) CEO Sells 5,000 Shares of Stock
Compugen Ltd. (NASDAQ:CGEN - Get Free Report) CEO Eran Ophir sold 5,000 shares of the stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $3.20, for a total...
MarketBeat·17d ago
News Placeholder
Compugen (NASDAQ:CGEN) Share Price Crosses Above 200-Day Moving Average - Here's What Happened
Compugen (NASDAQ:CGEN) Shares Pass Above 200 Day Moving Average - Time to Sell...
MarketBeat·21d ago
News Placeholder
Insider Selling: Compugen (NASDAQ:CGEN) CEO Sells 5,000 Shares of Stock
Compugen Ltd. (NASDAQ:CGEN - Get Free Report) CEO Eran Ophir sold 5,000 shares of the firm's stock in a transaction dated Tuesday, April 14th. The shares were sold at an average price of $2.90, for a total transaction of $14,500.00. Following the completion of the transaction, the chief executive...
MarketBeat·28d ago
News Placeholder
Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference
Compugen (NASDAQ:CGEN) outlined progress across its immuno-oncology pipeline and partnerships at the Needham & Company Healthcare Conference, emphasizing the company's AI-driven target discovery...
MarketBeat·1mo ago
<
1
2
...
>

Latest CGEN News

View
Top Discussions